Difficulty: Medium
Average Score: 75%
Practice
What are the most common immunosuppressive agents used to prevent rejection of transplanted organs?
Correct answer
D
Rationale
The correct answer is D) Tacrolimus, prednisone, and mycophenolate mofetil. These three immunosuppressive agents are commonly used in combination to prevent rejection of transplanted organs.
1. Tacrolimus: It is a calcineurin inhibitor that works by suppressing the immune response, particularly T-cell activation, which plays a crucial role in organ rejection.
2. Prednisone: A corticosteroid that helps reduce inflammation and suppress the immune system's activity, also decreasing the risk of rejection.
3. Mycophenolate mofetil: It inhibits the proliferation of T and B lymphocytes, which are involved in the rejection process.
Educational Context:
Understanding the mechanism of action of each immunosuppressive agent is crucial for healthcare professionals involved in transplant care. Knowledge of these medications helps in managing patients post-transplant to prevent rejection while balancing the risks of immunosuppression-related complications.
Now, let's discuss why the other options are incorrect:
A) Cyclosporine, sirolimus, and muromonab-CD3: While cyclosporine and sirolimus are indeed immunosuppressive agents used in transplantation, muromonab-CD3 is a monoclonal antibody used for acute rejection treatment, not prevention.
B) Prednisone, polyclonal antibodies, and cyclosporine: Prednisone and cyclosporine are commonly used, but polyclonal antibodies are not the standard agents for primary immunosuppression in organ transplantation.
C) Azathioprine, mycophenolate mofetil, and sirolimus: Azathioprine is an older immunosuppressant but is less commonly used now due to its side effect profile and efficacy compared to newer agents like mycophenolate mofetil. Sirolimus is used but not as commonly as tacrolimus in primary immunosuppression protocols.
In conclusion, understanding the rationale behind the correct answer and why other options are incorrect is essential for healthcare professionals to provide optimal care to transplant recipients.
1. Tacrolimus: It is a calcineurin inhibitor that works by suppressing the immune response, particularly T-cell activation, which plays a crucial role in organ rejection.
2. Prednisone: A corticosteroid that helps reduce inflammation and suppress the immune system's activity, also decreasing the risk of rejection.
3. Mycophenolate mofetil: It inhibits the proliferation of T and B lymphocytes, which are involved in the rejection process.
Educational Context:
Understanding the mechanism of action of each immunosuppressive agent is crucial for healthcare professionals involved in transplant care. Knowledge of these medications helps in managing patients post-transplant to prevent rejection while balancing the risks of immunosuppression-related complications.
Now, let's discuss why the other options are incorrect:
A) Cyclosporine, sirolimus, and muromonab-CD3: While cyclosporine and sirolimus are indeed immunosuppressive agents used in transplantation, muromonab-CD3 is a monoclonal antibody used for acute rejection treatment, not prevention.
B) Prednisone, polyclonal antibodies, and cyclosporine: Prednisone and cyclosporine are commonly used, but polyclonal antibodies are not the standard agents for primary immunosuppression in organ transplantation.
C) Azathioprine, mycophenolate mofetil, and sirolimus: Azathioprine is an older immunosuppressant but is less commonly used now due to its side effect profile and efficacy compared to newer agents like mycophenolate mofetil. Sirolimus is used but not as commonly as tacrolimus in primary immunosuppression protocols.
In conclusion, understanding the rationale behind the correct answer and why other options are incorrect is essential for healthcare professionals to provide optimal care to transplant recipients.